XML 20 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating activities:    
Net income $ 113.3 $ 107.4
Adjustments for items not affecting cash:    
Depreciation and amortization 114.5 107.7
Share-based payments expense 15.6 15.1
Deferred income tax benefit (5.0) (9.8)
Unrealized foreign exchange (gain) loss (0.3) 0.5
Gain on disposition of property, plant and equipment (0.4) (2.4)
Allowance for expected credit losses 1.1 3.2
Amortization of debt issuance costs 2.1 3.7
Amortization of right-of-use assets 38.7 37.5
Other, net 2.6 3.7
Net changes in operating assets and liabilities (125.4) (141.8)
Net cash provided by operating activities 156.8 124.8
Investing activities:    
Property, plant and equipment additions (54.3) (45.2)
Proceeds on disposition of property, plant and equipment 1.1 0.5
Intangible asset additions (27.7) (28.4)
Proceeds from repayment of loans receivable 1.4 0.9
Issuance of loans receivable (22.1) (4.4)
Other, net (0.3) (0.9)
Net cash used in investing activities (101.9) (77.5)
Financing activities:    
Dividends paid to common stockholders (53.5) (49.3)
Dividends paid to Series A Senior Preferred shareholders (8.6) (8.5)
Proceeds from exercise of options and share option plans 4.3 22.1
Payment of withholding taxes on issuance of shares (15.2) (10.4)
Net increase in short-term debt 34.5 11.7
Repayment of long-term debt (1.0) (151.1)
Repayment of finance lease and equipment financing obligations (6.5) (6.5)
Proceeds from equipment financing obligations 1.0 1.1
Net cash used in financing activities (45.0) (190.9)
Effect of changes in foreign currency rates on cash, cash equivalents, and restricted cash 3.1 (6.9)
Net increase (decrease) in cash, cash equivalents, and restricted cash 13.0 (150.5)
Cash, cash equivalents, and restricted cash, beginning of period 708.8 747.9
Cash, cash equivalents, and restricted cash, end of period $ 721.8 $ 597.4